High-level briefing: Sex change-backer wins $2M verdict | Must-knows for healthcare CEOs | Life expectancy up | Vociferous nurses revisited

A malpractice lawsuit filed by a gender detransitioner ended Jan. 30 with a victory for the aggrieved former patient. It was the first such suit to reach a jury. 

A detransitioner is a person who changes his or her mind after taking clinical steps to convincingly identify as a member of the opposite sex. The steps typically include psychological counseling, hormone treatments (including puberty-blocking drugs for children) and elective surgeries. 

• In the case at hand, Fox Varian, now 22, won a $2 million jury verdict Jan. 30 in White Plains, New York. The sum comprised $1.6 million for past and future pain and suffering plus $400,000 for future medical expenses.
   
• The crux of the suit was suffering and regret that Varian—birth name Isabella—experienced following a double mastectomy she received when she was 16 as part of a planned female-to-male transition. The defendants were the talk therapist who counseled Varian and the surgeon who performed the operation. The jury deliberated more than five hours before arriving at a decision. They found 70% of the fault for Varian’s avoidable mental anguish and physical injuries traced to guidance from psychologist Kenneth Einhorn, PhD. The jury split the $2M award proportionately between him and cosmetic surgeon Simon Chin, MD. 
   
• Journalist Benjamin Ryan was on scene for The Free Press in the courtroom for the full three-week trial. Noting that around 30 similar civil suits are headed toward or wending their way through the courts, Ryan points out the defendants in the Varian case may appeal. Either way, for now, the judgment sets a precedent as it frames an issue that’s become a flashpoint in the culture wars—and a point of contention within medical societies and among healthcare stakeholders nationwide. 
   
• From Ryan’s article, posted by the Free Press Feb. 1: 
   
  • The trial was anchored by emotional testimony from Varian and her mother, Claire Deacon. Varian testified that Einhorn “served as an enabler, repeatedly assuring her that the mastectomy she desired would greatly improve her well-being,” Ryan reports. Mom Deacon testified that Einhorn “browbeat her into consenting to her daughter’s surgery, threatening that [the then-teenager] would otherwise commit suicide.”
     
  • Shame and cognitive dissonance, Varian testified, kept her from openly confessing her remorse until three years following the mastectomy. “At 19, she finally stopped identifying and presenting as male and has since considered herself a woman,” Ryan writes. “But an incomplete one.”
     
  • “It’s so hard to face that you are disfigured for life,” Varian told the jury. Ryan reports: “The physical toll, Varian testified, includes scarring, lack of sensation in her nipples and nerve pain where her breasts once were. She will never be able to nurse an infant. ‘No amount of reconstruction,’ Varian testified, ‘is ever going to bring back what I lost.’”
     
  • Varian’s story is sure to supply fodder for the wider culture war. But the question for a jury in a medical malpractice case such as this is “whether the care providers failed to observe standard safeguards and whether any deviations from those standards injured the patient,” Ryan notes. 
     
  • Varian’s lawyer, personal-injury attorney Adam Deutsch, JD, argued that Einhorn and Chin “horrifically failed at meeting [established] standards of care to protect” a “fragile and vulnerable kid.” Dr. Einhorn’s obligation, Deutsch added, was “not to empower her with every crazy idea that came into the head of a 16-year-old kid.”
     
  • Legal experts tell the Free Press that further major jury awards could drive up malpractice insurance rates. The close case watchers said they wouldn’t be surprised if a series of such awards pushes fearful providers out of the field altogether. “At the very least,” reporter Ryan writes, “additional plaintiff victories could force pediatric gender medicine providers to reconsider hasty practices and observe greater caution when assessing minors for gender-transition interventions.” The next detransitioner civil trial, in Nebraska, is slated to begin in August, Ryan notes. 
     
  • The field is already undergoing a precipitous decline. “More than half of all U.S. states have banned gender-transition interventions for minors,” Ryan reports, “and President Donald Trump has made swift inroads in his own offensive by, most impactfully, threatening to pull Medicaid funding from hospitals that provide such treatments or surgeries.”
     
• The full article is available to Free Press subscribers here. 
   
  • For lots more coverage, see here.
     

The clinical workforce is structurally compromised as compounding staff-experience challenges intersect with complex patient demands.

The heads-up is from a report just out from the Advisory Board with Modern Healthcare. “Years of trauma, burnout and under-resourcing have left the clinical workforce in a fragile state,” the authors write, expounding on the point above. “Clinician shortages are projected to get worse. Provider organizations must confront the disconnect between enterprise strategy and frontline reality, redesigning roles, investing in retention and rebuilding trust to ensure sustainable, high-quality care delivery.” 

This is one of 12 “things healthcare CEOs need to know” in 2026. Others fleshed out in the 68-page report include:

• Federal public funding reductions will bring a generational rollback of safety net coverage. “A landmark law, along with sweeping regulations, is pulling back federal subsidization of healthcare through stricter eligibility and reduced funding levers,” the Advisory Board analysts explain. “Reductions in essential community access financing will bring significant increases in uninsured patients and uncompensated care for providers.”
   
  • That’s two down and 10 to go. The full report is downloadable here.
     

U.S. life expectancy at birth clocked in at 79 years in 2024. 

If we can add one more year we’ll hit a nice round milestone. Till then, it’s encouraging to know that 79 is good enough to rewrite the record books. More from the Jan. 29 CDC data brief revealing the good news:

• The age-adjusted death rate decreased 3.8% from 750.5 deaths per 100,000 U.S. standard population in 2023 to 722.1 in 2024.
   
• Age-specific death rates decreased from 2023 to 2024 for all age groups 1 year and older except for the 5–14 age group.
   
• Suicide replaced COVID-19 as the 10th leading cause of death, and heart disease, cancer and unintentional injuries remained the top 3 leading causes in 2024.
   
• The infant mortality rate did not change significantly from 2023 (560.2 infant deaths per 100,000 live births) to 2024 (552.5).

Of course, the hard data are dry, as data without comment tend to be. A couple of remarks worth noting: 

• In 2024 America fully recovered from the pandemic decline, and death rates decreased from the top causes of death. “Americans have superior medical access. … America’s private health system isn’t without flaws—which largely stem from market distortions caused by government—but it’s better than the alternatives.”—The editorial board of the Wall Street Journal 
   
• The data reflect not only a complete turnaround from the pandemic but also a lasting improvement in the drug overdose epidemic, says Andrew Stokes, a researcher at Boston University. The bad news is that the U.S. still ranks below dozens of other countries, Stokes notes before adding: “There’s a lot more to be done.”—AP via the Los Angeles Times 
   

Also of interest:

• COVID-19 vaccine policy: a response and way forward: Prasad and Makary’s proposed COVID-19 vaccine policy seeks to restore public trust through a risk-based, evidence-driven approach. However ... (Vaccine journal) 
   
• Fluoride ban efforts show RFK Jr.’s reach ... New fluoride limits could upend an 80-year-old standard that's widely credited with reducing tooth decay by 25% and narrowing disparities for people without regular dental care. (Axios)
   
• How afraid of nurses should we be? ... Are there private “#MeToo-style lists that nurses share about patients? If so, that needs to be exposed and prosecuted, if HIPAA laws were broken. (Rod Dreher’s Diary) 

From HealthExec’s sibling news outlets:

• Georgia jury sides with radiologist in negligence case (Radiology Business)
   
• Men developed CVD earlier than women, according to 35-year CARDIA study (Cardiovascular Business)